A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
about
Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and TherapyPhase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphomaImexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase.Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damageAnti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423.Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells.Pancreatic cancer: chemotherapy and radiotherapy.Magnetic Resonance Imaging Identifies Differential Response to Pro-Oxidant Chemotherapy in a Xenograft Model.Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.Cellular redox pathways as a therapeutic target in the treatment of cancer.Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma.
P2860
Q26740191-6FB4C5C4-A9ED-46F2-9AFF-874FC7B40C37Q34077774-0E97F355-00D1-4E1A-9D7D-752856F20454Q34329957-E725203C-8E07-40EA-A1B6-DA702885AF73Q34720428-27D50F3D-F9CB-4E1F-A741-02E4C3A62FEFQ35857055-A6F2C49C-AA6F-40CE-A243-A90DDE3E94C7Q35883238-D5B7FCB5-69D4-47C1-9791-8CF06754EC37Q35913523-03380B3D-B34A-4B93-89D1-28D4CE277D88Q37004328-0B8A097B-45F6-40A1-9441-12D8192A94F7Q37699339-C2AC20F5-BC06-4472-B093-A88A77139D08Q37845832-B6A32BE0-8250-4452-9F55-74D39D0F12A7Q37910897-608FF098-C5A1-4BD0-A83F-28D7375DD82FQ42040315-391BC3C8-63C9-4696-949C-D41DE2A1D3D5
P2860
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A phase I study of imexon plus ...... or advanced pancreatic cancer.
@ast
A phase I study of imexon plus ...... or advanced pancreatic cancer.
@en
type
label
A phase I study of imexon plus ...... or advanced pancreatic cancer.
@ast
A phase I study of imexon plus ...... or advanced pancreatic cancer.
@en
prefLabel
A phase I study of imexon plus ...... or advanced pancreatic cancer.
@ast
A phase I study of imexon plus ...... or advanced pancreatic cancer.
@en
P2093
P2860
P1476
A phase I study of imexon plus ...... or advanced pancreatic cancer.
@en
P2093
Evan M Hersh
Manuel R Modiano
Mark M Zalupski
Michelle L Boytim
Paul Conkling
Robert T Dorr
Steven J Cohen
Yehuda Z Patt
P2860
P2888
P304
P356
10.1007/S00280-009-1162-Y
P577
2009-10-24T00:00:00Z
P5875
P6179
1009606003